Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 60 (4) , 259-268
- https://doi.org/10.1016/0049-3848(90)90105-l
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS studyThe Lancet, 1990
- Interactions between pharmacologic concentrations of plasminogen activators and plateletsFibrinolysis, 1989
- Pharmacological comparison of anisoylated lys-plasminogen streptokinase activator complex with its glu-plasminogen variant and streptokinase-gluplasminogen: Binding to human fibrin and plasma clotsFibrinolysis, 1989
- An investigation of methods to prevent fibrinogen degradation during processing of plasma samples containing the fibrinolytic agents, APSAC and t-PAFibrinolysis, 1989
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.Circulation, 1988
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbitThrombosis Research, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Clinical effects and kinetic properties of intravenous APSAC — anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarctionInternational Journal of Cardiology, 1986